Skip to search formSkip to main contentSkip to account menu

PrepaCyte-CB

Known as: PrepaCyte 
A proprietary system for processing and storing total nucleated cells from human umbilical cord blood before banking.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit
Bone marrow (BM) grafts are often subject to manipulation to minimize infusion volume, to deplete red blood cells (RBCs), to… 
2017
2017
Comparison of Processing Reagents (Hespan and PrepaCyte-CB®) in Preparation of Cord Blood Units at the Saint Louis Cord Blood Bank
2015
2015
Equine bone marrow volume reduction, red blood cell depletion, and mononuclear cell recovery using the PrepaCyte-CB processing system.
BACKGROUND Volume reduction and RBC depletion of equine bone marrow specimens are necessary processing steps for the immediate… 
2013
2013
Sterility testing of minimally manipulated cord blood products: validation of growth‐based automated culture systems
The St Louis Cord Blood Bank submitted a biologics license application for cord blood (CB) products processed by PrepaCyte‐CB… 
2012
2012
Neurogenic properties and a clinical relevance of multipotent stem cells derived from cord blood samples stored in the biobanks.
Several innovative therapies with human umbilical cord blood stem cells (SCs) are currently developing to treat central nervous… 
2009
2009
Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells.
BACKGROUND AIMS A robust methodology for the isolation of cord blood-derived multipotent mesenchymal stromal cells (CB-MSCs) from… 
2007
2007
Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry.
2006
2006
26: Isolation and Characterization of Umbilical Cord Blood-Derived Multipotent Stem Cells Arising from an Adherent CD45+/CD34+ Cell Subset
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)